Manchester BRC researchers have launched a trial on a bedside genetic test that will predict whether newborn babies receiving antibiotics in intensive care are at risk of irreversible hearing loss.
Hearing Health Lead Professor Kevin Munro has become a Principal Fellow of The British Society of Audiology (BSA) and North West Committee Chair of the NIHR Research for Patient Benefit (RfPB) programme.
Manchester BRC Hearing Health Lead Kevin Munro welcomes the launch of the “Hearing Medicines Discovery Syndicate,”a unique collaboration to accelerate the much-needed development of treatments for hearing loss and tinnitus.
Professor Kevin J Munro, NIHR Manchester Biomedical Research Centre (BRC) Hearing Health Theme Lead, concludes a series of thought provoking blogs by our Manchester BRC Hearing Health researchers.
In his blog Professor Chris Plack discusses the importance of measuring hearing sensitivity at very high frequencies, beyond the range normally tested in the clinic.
Professor Cynthia Morton, Programme Lead for Genetic and Genomic Solutions, discusses her project to expand newborn hearing screening to include genetic screening for variants in genes known to cause deafness.
In his blog Christopher Armitage, Professor of Health Psychology and Manchester BRC Optimising Outcomes Programme Lead, discusses hearing loss and its image problem.
Helen Whiston, Research Audiologist highlights how Manchester BRC and Manchester Clinical Research Facility are supporting the design of a new, quick, easy and robust speech-in-noise test for children.